Sofosbuvir + Ribavirin Cures Many with Hepatitis C in Phase II Clinical Trial
Share
Follow Us
The Editors at Hepatitis Central
August 28, 2013
Read the details about a Phase II Clinical Trial which highlights compelling evidence that interferon-free regimens can be safe and effective.
Hepatitis C Cure? Sofosbuvir Plus Ribavirin Eliminate Liver Infection In Promising NIH Trial
By Nsikan Akpan | Aug 27, 2013
Hepatitis C patients who don’t normally respond to standard treatment may have a new weapon for fighting their viral liver disease. A combination drug program, with sofosbuvir and ribavirin, has cured a majority of volunteers in a Phase II clinical trial conducted by the National Institute of Allergy and Infectious Disease (NIAID), a branch of the National Institutes of Health (NIH).
Continue reading this entire article:
http://www.medicaldaily.com/hepatitis-c-cure-sofosbuvir-plus-ribavirin-eliminate-liver-infection-promising-nih-trial-254613
